Sunmax Biotechnology Co., Ltd. - Laporan Laba Rugi (TTM)

Sunmax Biotechnology Co., Ltd.
TW ˙ TPEX
NT$ 265.00 ↑1.00 (0.38%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sunmax Biotechnology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 637 856 1,016 1,023 1,082 1,036 1,093 1,181 1,292 1,400 1,468 1,564 1,674 1,689 1,724 1,760 1,743 1,818 1,945 1,951
Change (%) 34.38 18.73 0.67 5.81 -4.32 5.57 7.98 9.42 8.38 4.88 6.50 7.06 0.88 2.04 2.10 -0.93 4.28 6.96 0.33
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 128 155 163 173 146 141 165 175 193 207 214 245 269 284 301 303 314 339 382 401
Change (%) 20.53 5.68 6.15 -15.58 -3.58 16.77 6.25 10.28 7.28 3.24 14.66 9.78 5.47 5.86 0.65 3.85 7.95 12.54 4.89
% of Revenue 20.15 18.07 16.08 16.96 13.53 13.63 15.08 14.84 14.96 14.80 14.57 15.69 16.09 16.82 17.45 17.20 18.03 18.67 19.64 20.53
Gross Operating Profit 509 701 853 850 936 894 928 1,005 1,099 1,193 1,254 1,319 1,405 1,405 1,423 1,457 1,429 1,479 1,563 1,550
Change (%) 37.87 21.61 -0.38 10.17 -4.44 3.81 8.28 9.27 8.58 5.16 5.11 6.55 0.00 1.27 2.41 -1.93 3.48 5.68 -0.78
% of Revenue 79.85 81.93 83.92 83.04 86.47 86.37 84.92 85.16 85.04 85.20 85.43 84.31 83.91 83.18 82.55 82.80 81.97 81.33 80.36 79.47
SG&A 329 351 450 491 520 502 428 389 361 407 437 474 496 481 486 483 483 513 526 540
Change (%) 6.84 28.04 9.25 5.78 -3.36 -14.91 -9.11 -7.13 12.74 7.41 8.55 4.54 -2.92 0.96 -0.55 -0.13 6.18 2.58 2.65
% of Revenue 51.64 41.05 44.27 48.04 48.03 48.51 39.10 32.91 27.94 29.06 29.76 30.33 29.62 28.50 28.20 27.46 27.69 28.19 27.04 27.66
R&D 17 18 17 17 21 25 24 20 18 18 20 23 28 29 32 35 33 39 44 50
Change (%) 0.54 -3.62 1.67 22.67 16.86 -4.13 -13.43 -10.64 -1.61 13.56 11.56 23.05 2.59 10.46 11.07 -7.11 19.62 12.36 14.49
% of Revenue 2.74 2.05 1.66 1.68 1.95 2.38 2.16 1.73 1.41 1.28 1.39 1.46 1.67 1.70 1.84 2.00 1.88 2.16 2.26 2.58
OpEx 475 524 630 682 687 668 616 584 572 632 671 742 793 794 818 821 830 891 952 991
Change (%) 10.31 20.37 8.24 0.78 -2.78 -7.82 -5.17 -2.03 10.44 6.22 10.59 6.84 0.12 3.06 0.34 1.04 7.38 6.80 4.09
% of Revenue 74.52 61.17 62.02 66.68 63.51 64.53 56.34 49.48 44.31 45.15 45.72 47.48 47.38 47.02 47.49 46.67 47.60 49.01 48.94 50.78
Operating Income 162 332 386 341 395 367 477 596 719 768 797 821 881 895 905 938 914 927 993 960
Change (%) 104.78 16.15 -11.69 15.87 -6.99 29.94 24.94 20.64 6.75 3.78 3.06 7.25 1.56 1.15 3.69 -2.66 1.47 7.11 -3.27
% of Revenue 25.48 38.83 37.98 33.32 36.49 35.47 43.66 50.52 55.69 54.85 54.28 52.52 52.62 52.98 52.51 53.33 52.40 50.99 51.06 49.22
Interest Expense -3 -3 -3 -3 -3 -3 -2 -2 -2 -1 -1 -1 -2 -3 -4 -5 -6 -6 -6 -5
Change (%) 8.73 6.17 4.04 -5.12 -8.15 -12.54 -14.51 -18.40 -21.44 -3.12 -4.07 32.96 77.02 39.97 29.38 14.34 -2.30 -4.57 -5.83
% of Revenue -0.42 -0.34 -0.30 -0.31 -0.28 -0.27 -0.22 -0.18 -0.13 -0.10 -0.09 -0.08 -0.10 -0.17 -0.24 -0.30 -0.35 -0.33 -0.29 -0.27
Net Income 70 238 294 254 277 246 316 410 506 534 529 535 582 626 674 712 699 679 726 699
Change (%) 240.99 23.65 -13.65 8.94 -11.29 28.51 29.93 23.33 5.53 -0.90 1.04 8.81 7.57 7.70 5.62 -1.80 -2.80 6.91 -3.78
% of Revenue 10.96 27.82 28.97 24.85 25.58 23.72 28.87 34.74 39.16 38.13 36.03 34.18 34.74 37.05 39.10 40.45 40.09 37.37 37.35 35.82

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista